Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis.

A. Calin, R. M. Bennett, S. Sukhupunyaraksa, A. L. Goldman, H. E. Montoya, W. M. O'Brien, V. J. Giuliano, F. R. Schmid, R. F. Willkens, H. Y. Sakofsky

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

A double-blind parallel multi-centre study of 102 patients with rheumatoid arthritis (RA) was performed, comparing ibuprofen (1200-2400 mg daily) and ketoprofen (150-300 mg daily) a new non-steroidal, anti-inflammatory agent, over a three month period. Ketoprofen was well tolerated and shown to have comparable efficacy with ibuprofen. Longterm efficacy and tolerance studies are indicated.

Original languageEnglish (US)
Pages (from-to)153-157
Number of pages5
JournalJournal of Rheumatology
Volume4
Issue number2
StatePublished - Jun 1977
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Fingerprint

Dive into the research topics of 'Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis.'. Together they form a unique fingerprint.

Cite this